Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development
Editat de Kunal Royen Limba Engleză Paperback – 25 mai 2023
The first part of the content is devoted to establishing the foundations of the area. Here recent trends in computational modeling of drugs are presented. Other topics present in this part include QSAR in medicinal chemistry, structure-based methods, chemoinformatics and chemometric approaches, and machine learning methods in drug design. The second part focuses on methods and case studies including molecular descriptors, molecular similarity, structure-based based screening, homology modeling in protein structure predictions, molecular docking, stability of drug receptor interactions, deep learning and support vector machine in drug design. The third part of the book is dedicated to special topics, including dedicated chapters on topics ranging from de design of green pharmaceuticals to computational toxicology. The final part is dedicated to present the available tools and databases, including QSAR databases, free tools and databases in ligand and structure-based drug design, and machine learning resources for drug design. The final chapters discuss different web servers used for identification of various drug candidates.
- Presents chemometrics, cheminformatics and machine learning methods under a single reference
- Showcases the different structure-based, ligand-based and machine learning tools currently used in drug design
- Highlights special topics of computational drug design and available tools and databases
Preț: 1019.55 lei
Preț vechi: 1267.60 lei
-20% Nou
Puncte Express: 1529
Preț estimativ în valută:
195.15€ • 205.03$ • 164.01£
195.15€ • 205.03$ • 164.01£
Carte tipărită la comandă
Livrare economică 05-19 martie
Livrare express 04-08 februarie pentru 264.98 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443186387
ISBN-10: 0443186383
Pagini: 768
Dimensiuni: 191 x 235 x 116 mm
Greutate: 1.57 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443186383
Pagini: 768
Dimensiuni: 191 x 235 x 116 mm
Greutate: 1.57 kg
Editura: ELSEVIER SCIENCE
Public țintă
Primarily academics covering PhD, Post-docs and Masters students of Pharmaceutical Sciences and Chemistry in generalCuprins
Section I: Introduction
1. Quantitative structure-activity relationships (QSARs) in medicinal chemistry
2. Computer-aided Drug Design – An overview
3. Structure-based virtual screening in Drug Discovery
4. The impact of Artificial Intelligence methods on drug design
Section 2. Methods and Case studies
5. Graph Machine Learning in Drug Discovery
6. Support Vector Machine in Drug Design
7. Understanding protein-ligand interactions using state-of-the-art computer simulation methods
8. Structure-based methods in drug design
9. Structure-based virtual screening
10. Deep learning in drug design
11. Computational methods in the analysis of viral-host interactions
12. Chemical space and Molecular Descriptors for QSAR studies
13. Machine learning methods in drug design
14. Deep learning methodologies in drug design
15. Molecular dynamics in predicting stability of drug receptor interactions
Section 3. Special topics
16. Towards models for bioaccumulation suitable for the pharmaceutical domain
17. Machine Learning as a Modeling Approach for the Account of Nonlinear Information in MIA-QSAR Applications: A Case Study with SVM Applied to Antimalarial (Aza)aurones
18. Deep Learning using molecular image of chemical structure
19. Recent Advances in Deep Learning Enabled Approaches for Identification of Molecules of Therapeutics Relevance
20. Computational toxicology of pharmaceuticals
21. Ecotoxicological QSAR modelling of pharmaceuticals
22. Computational modelling of drugs for neglected diseases
23. Modelling ADMET properties based on Biomimetic Chromatographic Data
24. A systematic chemoinformatic analysis of chemical space, scaffolds and antimicrobial activity of LpxC inhibitors
Section 4. Tools and databases
25. Tools and Software for Computer Aided Drug Design and Discovery
26. Machine learning resources for drug design
27. Building Bioinformatics Web Applications with Streamlit
28. Free tools and databases in ligand and structure-based drug design
1. Quantitative structure-activity relationships (QSARs) in medicinal chemistry
2. Computer-aided Drug Design – An overview
3. Structure-based virtual screening in Drug Discovery
4. The impact of Artificial Intelligence methods on drug design
Section 2. Methods and Case studies
5. Graph Machine Learning in Drug Discovery
6. Support Vector Machine in Drug Design
7. Understanding protein-ligand interactions using state-of-the-art computer simulation methods
8. Structure-based methods in drug design
9. Structure-based virtual screening
10. Deep learning in drug design
11. Computational methods in the analysis of viral-host interactions
12. Chemical space and Molecular Descriptors for QSAR studies
13. Machine learning methods in drug design
14. Deep learning methodologies in drug design
15. Molecular dynamics in predicting stability of drug receptor interactions
Section 3. Special topics
16. Towards models for bioaccumulation suitable for the pharmaceutical domain
17. Machine Learning as a Modeling Approach for the Account of Nonlinear Information in MIA-QSAR Applications: A Case Study with SVM Applied to Antimalarial (Aza)aurones
18. Deep Learning using molecular image of chemical structure
19. Recent Advances in Deep Learning Enabled Approaches for Identification of Molecules of Therapeutics Relevance
20. Computational toxicology of pharmaceuticals
21. Ecotoxicological QSAR modelling of pharmaceuticals
22. Computational modelling of drugs for neglected diseases
23. Modelling ADMET properties based on Biomimetic Chromatographic Data
24. A systematic chemoinformatic analysis of chemical space, scaffolds and antimicrobial activity of LpxC inhibitors
Section 4. Tools and databases
25. Tools and Software for Computer Aided Drug Design and Discovery
26. Machine learning resources for drug design
27. Building Bioinformatics Web Applications with Streamlit
28. Free tools and databases in ligand and structure-based drug design